Abstract: A patient interface system for delivering a flow of breathable gas to a patient includes a patient interface structure configured to sealingly engage the patient's nares; a pair of strips configured to be connected to opposite sides of the patient interface structure; and adhesive configured to secure the patient interface structure in sealing engagement with the patient's nares. The adhesive may be provided on the strips, and the strips are configured to be adhered to sides of the patient's nose by the adhesive.

Abstract: A mask system for use between a patient and a structure to deliver a breathable gas to the patient includes a mask assembly including a frame, a cushion provided to the frame, and optionally an elbow provided to the frame. Headgear is removably attached to the mask assembly to maintain the mask assembly in a desired position on a patient's face. The headgear includes a top strap, crown straps which cooperate to form a round shape adapted to accommodate a crown of the patient's head, and bottom straps.

Abstract: A patient interface system for delivering a flow of breathable gas to a patient includes a patient interface structure configured to sealingly engage the patient's nares; a pair of strips configured to be connected to opposite sides of the patient interface structure; and adhesive configured to secure the patient interface structure in sealing engagement with the patient's nares. The adhesive may be provided on the strips, and the strips are configured to be adhered to sides of the patient's nose by the adhesive. Another patient interface system includes a first component including adhesive on a first side and hook or loop fastener material on a second side, wherein the adhesive is configured to adhere the component to the face of the patient; and a patient interface structure configured to sealingly engage the patient's airways.

Abstract: A mask system for use between a patient and a structure to deliver a breathable gas to the patient includes a mask assembly including a frame, a cushion provided to the frame, and optionally an elbow provided to the frame. Headgear is removably attached to the mask assembly to maintain the mask assembly in a desired position on a patient's face. The headgear includes a back headgear section providing a top strap, a pair of side straps attached to the back headgear section, and an elastic strap attached between the back headgear section and the pair of side straps.

Abstract: A drum maintenance system for use in an imaging device includes a reservoir for the storage of release agent used by the drum maintenance unit. The reservoir includes a bottle, an end cap, and a float sensor. The float sensor has a buoyant member that is pivotably coupled to a proboscis extending from the end cap into the bottle and movement of the buoyant member enables detection of the release agent in the bottle reaching a predetermined level.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO227, PRO233, PRO238, PRO1328, PRO4342, PRO7423, PRO10096, PRO21384, PRO353 or PRO1885 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO224, PRO9783, PRO1108, PRO34000, PRO240, PRO943, hu A33, PRO230, PRO178, PRO1199, PRO4333, PRO1336, PRO19598, PRO1083, hu TRPM2 or PRO1801 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Abstract: A mask system includes a frame (20) adapted to attach headgear, a sealing arrangement (40) releasably connectable to the frame, and an elbow (70) provided to the sealing arrangement and adapted to be connected to an air delivery tube that delivers breathable gas to the patient. The sealing arrangement defines a breathing chamber and is adapted to form a seal with the patient's face. The sealing arrangement includes structure (50) to establish a positive connection with the frame and with the elbow.

Abstract: A drum maintenance system for use in an imaging device includes a reservoir for the storage of release agent used by the drum maintenance unit. The reservoir includes a bottle, an end cap, and a float sensor. The float sensor operates to detect the release agent in the bottle reaching a predetermined minimum level.

Abstract: An adjustable mask system (100) includes a cushion with a seal (130) having the ability to change size and/or shape. The seal is preferably a one-piece, continuous member without interruptions. To effect adjustment of the size and/or shape of the seal, an actuator may be provided, which may take the form of a dial (190).

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes.

Abstract: A porous structure sealed at both ends for use in a gas separation module; and a method for separating components of a gas stream.

Abstract: We describe a method of determining deformation data for an imaged object, the method comprising: inputting first and second sets of image data corresponding to different deformations of the imaged object, each comprising imaging signal data for an imaging signal, said imaging signal data including at least signal phase data; and determining, for at least one point in said first set of image data, a corresponding displacement for said point in said second set of image data; wherein the displacement determining comprises: initialising a value of displacement; determining an adjusted value for said displacement to provide said corresponding displacement, said determining of an adjusted value comprising: determining an average of differences in signal phase between corresponding positions in said first and second sets of image data, said corresponding positions being determined by a current value of said displacement; and using said average to determine said adjusted displacement value.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO188, PRO235, PRO266, PRO337, PRO361, PRO539, PRO698, PRO717, PRO846, PRO874, PRO98346, PRO1082, PRO1097, PRO1192, PRO1268, PRO1278, PRO1303, PRO1308, PRO1338, PRO1378, PRO1415, PRO1867, PRO1890, PRO3438, PRO19835, PRO36915, PRO36029, PRO4999, PRO5778, PRO5997, PRO6079, PRO6090, PRO7178, PRO21184, PRO7434, PRO9822, PRO9833, PRO9836, PRO9854, PRO9862, PRO10284, PRO37510, PRO35444, PRO20473, PRO21054 or PRO35246 genes.

Abstract: Described herein is a cordierite membrane coated on a monolith substrate formed from cordierite. The membrane coating is formed from cordierite particles which have been processed to have a median particle size diameter of between 1 and 3 microns with a narrow particle size distribution suitable for forming a cordierite membrane on a cordierite monolith substrate. After the cordierite membrane is formed on the cordierite monolith substrate, the cordierite membrane monolith has a pore size of less than 1 micron.

Abstract: A method of servicing a customer replaceable unit of an imaging device includes providing a customer replaceable unit configured for insertion and removal from an imaging device. The customer replaceable unit includes at least an applicator configured to apply a release agent to a surface of an intermediate transfer drum of the imaging device, a reservoir including a supply of the release agent for the applicator, a delivery pump configured to pump release agent from the reservoir to the applicator, a recirculation pump configured to pump release agent from the applicator to the reservoir, and a memory including operational data for the customer replaceable unit. A maintenance procedure is then performed on the customer replaceable unit.

Abstract: A drum maintenance system for use in an imaging device includes a reservoir for the storage of release agent used by the drum maintenance unit. The reservoir includes a bottle, an end cap, and a float sensor. The float sensor operates to detect the release agent in the bottle reaching a predetermined minimum level.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO227, PRO233, PRO238, PRO1328, PRO4342, PRO7423, PRO10096, PRO21384, PRO353 or PRO1885 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO179, PRO181, PRO244, PRO247, PRO269, PRO293, PRO298, PRO339, PRO341, PRO347, PRO531, PRO537, PRO718, PRO773, PRO860, PRO871, PRO872, PRO813, PRO828, PRO1100, PRO1114, PRO115, PRO1126, PRO1133, PRO1154, PRO1185, PRO1194, PRO1287, PRO1291, PRO1293, PRO1310, PRO1312, PRO1335, PRO1339, PRO2155, PRO1356, PRO1385, PRO1412, PRO1487, PRO1758, PRO1779, PRO1785, PRO1889, PRO90318, PRO3434, PRO3579, PRO4322, PRO4343, PRO4347, PRO4403, PRO4976, PRO260, PRO6014, PRO6027, PRO6181, PRO6714, PRO9922, PRO7179, PRO7476, PRO9824, PRO19814, PRO19836, PRO20088, PRO70789, PRO50298, PRO51592, PRO1757, PRO4421, PRO9903, PRO1106, PRO1411, PRO1486, PRO1565, PRO4399 or PRO4404 genes.